US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 1.8100
  • -0.0400-2.16%
Trading Dec 23 15:32 ET
370.95MMarket Cap2.87P/E (TTM)

Taysha Gene Therapies Key Stats

EPS
According to the latest financial report of Taysha Gene Therapies, the latest earnings per share (TTM) for the company is -0.10. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about Taysha Gene Therapies's free cash flow? The latest report shows it as -21.65M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Taysha Gene Therapies shows that the company's current ratio is 5.51, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Taysha Gene Therapies, the quick ratio is 5.38, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of Taysha Gene Therapies? The latest ROE figure is -25.83%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Taysha Gene Therapies, the total asset return on investment (ROA) is -13.41%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Taysha Gene Therapies's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Taysha Gene Therapies, the net profit margin is -1.43K%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.